Quantcast

Latest dialysis Stories

2014-01-28 12:29:43

New Alternative for DC Residents Seeking Transplant WASHINGTON, Jan 28, 2014 /PRNewswire-USNewswire/ -- The George Washington University Hospital is pleased to announce that a District of Columbia administrative law judge has given the hospital permission to initiate a kidney and pancreas transplant program. This decision now opens the doors to people in the District of Columbia to have the opportunity to receive treatment for kidney and pancreatic diseases at The George Washington...

2014-01-24 23:00:59

The Firm is representing numerous individuals in GranuFLo lawsuits that allege serious heart injuries due to GranuFlo and NaturaLyte dialysis drugs. New York, New York (PRWEB) January 24, 2014 GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) filed in the wake of the 2012 recall of GranuFlo and NaturaLyte dialysis drugs continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, one of the most recent claims was filed in the U.S....

2014-01-24 11:33:02

Patients with sickle cell trait require more anemia drugs The presence of sickle cell trait among African Americans may help explain why those on dialysis require higher doses of an anemia medication than patients of other ethnicities, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Additional studies are needed to determine the long-term health consequences of this increased dosing. Sickle cell trait represents the...

2014-01-20 23:20:20

The Firm’s attorneys are actively filing dialysis lawsuit claims on behalf of individuals who may have experienced serious heart problems following their use of GranuFlo and/or NaturaLyte. New York, NY (PRWEB) January 20, 2014 In just under a month, court documents show that nearly 30 GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) have joined the federal dialysis drug litigation now underway in the U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP reports....

2014-01-18 23:01:13

The Firm is investigating dialysis lawsuits on behalf of individuals who allegedly suffered heart attacks, strokes, sudden cardiac death, and other catastrophic health problems allegedly related to Fresenius Medical Care’s 2012 GranuFlo and NaturaLyte recall. New York, New York (PRWEB) January 18, 2014 As GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) filed in the wake of the 2012 recall of GranuFlo and NaturaLyte dialysis drugs continue to move forward in courts around the...

2014-01-17 08:23:10

Marketing Approval Triggers Milestone Payment to Keryx NEW YORK, Jan. 17, 2014 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that its Japanese partner, Japan Tobacco Inc. (JT), has received manufacturing and marketing approval of ferric citrate from the Japanese Ministry of Health, Labour and Welfare. Ferric citrate, to be marketed in Japan by JT's subsidiary, Torii Pharmaceutical Co., Ltd., under the brand name Riona(®), is indicated as an oral...

2014-01-16 04:20:40

GLENDALE, Calif., Jan. 16, 2014 /PRNewswire-USNewswire/ -- Prom season comes early for hundreds of teens and young adults (14 to 24 years old) who have kidney disease, who are on dialysis or who have had a transplant. Renal Support Network (RSN) steps out onto the dance floor Sunday, January 19, 2014, to host the 15(th) Annual Renal Teen Prom for these teens and their guests. Last week attendees and guests took their pick of evening gowns that were donated especially for the event. This...

2014-01-14 12:27:26

NEW YORK, Jan. 14, 2014 /PRNewswire/ -- As hundreds of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) filed in the wake of the 2012 GranuFlo and NaturaLyte dialysis drug recall continue to move forward in courts around the country, Bernstein Liebhard LLP notes that a federal judge in Missouri has granted a motion filed by plaintiffs in one such case to remand the claim to state court in St. Louis. In an Order dated January 9, 2014, Magistrate Judge Thomas C. Mummert III of the...

2014-01-13 04:20:59

STOCKHOLM, January 13, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces it has completed recruitment of patients into a Phase IIb NEFIGAN study of its orphan drug product, Nefecon(R) (http://www.nefigan.net). Pharmalink expects to announce top-line results in mid-2015. The Phase IIb study is a multi-center, randomized, double-blinded placebo-controlled clinical trial designed to assess the efficacy and safety...

2014-01-10 16:21:55

DUBLIN, January 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/j635wj/nephrology_and) has announced the addition of the "2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/j635wj/nephrology_and ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.